| | | | | |
AGIO Agios Pharmaceuticals, Inc. | €23,8614 | +4,40% | €1,50B | €585,52K | |
SGRY Surgery Partners, Inc. Common Stock | €11,6397 | -1,96% | €1,50B | €1,21M | |
GAB The Gabelli Equity Trust Inc. | €4,8369 | -0,18% | €1,50B | €664,14K | |
HURN Huron Consulting Group Inc. | €90,3198 | -1,74% | €1,50B | €170,85K | |
ENVX Enovix Corporation Common Stock | €7,0873 | -4,64% | €1,50B | €6,21M | |
PAYO Payoneer Global Inc. Common Stock | €4,3843 | -4,95% | €1,50B | €4,00M | |
ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund | €12,8985 | +0,07% | €1,49B | €139,43K | |
STGW Stagwell Inc. Class A Common Stock | €5,6819 | -8,47% | €1,49B | €1,48M | |
CASH Pathward Financial, Inc. Common Stock | €66,9757 | -4,58% | €1,49B | €320,14K | |
SNDX Syndax Pharmaceuticals, Inc. | €15,8171 | -0,25% | €1,49B | €1,07M | |
STRA Strategic Education, Inc. Common Stock | €68,1483 | -0,15% | €1,49B | €152,15K | |
CAPR Capricor Therapeutics Inc | €23,8571 | +1,21% | €1,49B | €573,15K | |
AAPG Ascentage Pharma Group International American Depository Shares | €15,3687 | -3,39% | €1,49B | €19,46K | |
SLS SELLAS Life Sciences Group, Inc. Common Stock | €7,0614 | -1,68% | €1,49B | €6,42M | |
PLSE Pulse Biosciences, Inc Common Stock (DE) | €21,5550 | +2,97% | €1,49B | €225,44K | |
